Kala Bio (KALA) Raw Materials (2018 - 2019)

Kala Bio (KALA) posted Raw Materials of $706000.0 for Q2 2019, up 43.79% sequentially from $491000.0 in Q1 2019.

Kala Bio (KALA) Raw Materials (2018 - 2019) Analysis & Trends

Kala Bio has reported Raw Materials for 2 years, with the latest figure at $706000.0 in Q2 2019.

Quarterly Raw Materials changed N/A year-over-year to $706000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $706000.0 (changed N/A YoY) and the FY2018 annual result came in at $350000.0, changed N/A from the prior year.
Raw Materials rose to $706000.0 in Q2 2019 per KALA's latest filing, from $491000.0 in the prior quarter.
Over five years, Raw Materials peaked at $706000.0 in Q2 2019 and troughed at $350000.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Kala Bio	9.87 Mn	9.87 Mn	-

Download Data